Search results
Myriad Genetics (MYGN) Announces Favorable Research Results
Zacks via Yahoo Finance· 2 months agoMyriad Genetics, Inc. MYGN recently announced results from a multi-year, real-world study that...
Myriad Genetics (MYGN) Unveils GeneSight Test Enhancement
Zacks via Yahoo Finance· 10 months agoMyriad Genetics, Inc. MYGN recently announced improvements to the GeneSight Psychotropic test, a...
Here's Why You Should Retain Myriad Genetics (MYGN) Stock Now
Zacks via Yahoo Finance· 9 months agoMyriad Genetics MYGN is well poised for growth in coming quarters, backed by a substantial...
Here's Why Investors Should Hold Myriad Genetics (MYGN) Now
Zacks via Yahoo Finance· 2 years agoMyriad Genetics, Inc. MYGN has been gaining from continuous recovery in testing volumes. The robust...
Myriad Genetics (MYGN) Adds ARR to Prolaris Biomarker Test
Zacks via Yahoo Finance· 10 months agoMyriad Genetics, Inc. MYGN recently announced the addition of Absolute Risk Reduction (“ARR”) to the...
Is Myriad Genetics (MYGN) Too Good to Be True? A Comprehensive Analysis of a Potential Value Trap
GuruFocus.com via Yahoo Finance· 9 months agoValue-focused investors are always on the hunt for stocks that are priced below their intrinsic...
Myriad Genetics Reports Q1 2024 Earnings: Revenue Growth Surpasses Estimates Amidst Challenges
GuruFocus.com via Yahoo Finance· 1 month agoRevenue: Reported at $202 million for Q1 2024, marking a 12% increase year-over-year, surpassing the...
Myriad Genetics Inc (MYGN) Reports 11% Revenue Growth in Q4 and Full-Year 2023
GuruFocus.com via Yahoo Finance· 4 months agoRevenue Growth: Myriad Genetics Inc (NASDAQ:MYGN) reported an 11% year-over-year increase in both Q4...
Myriad Genetics (MYGN) Q2 Earnings Top, Gross Margin Down
Zacks via Yahoo Finance· 2 years agoMyriad Genetics, Inc. MYGN reported adjusted earnings per share (EPS) of 4 cents in the second...